The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) seeks applications for a research center grant to conduct cross-cutting research on alcohol and HIV/AIDS. Through this FOA, NIAAA seeks to encourage research applications aimed to address the impact of alcohol use on the most important challenges for ending HIV/AIDS pandemic, outlined as the high priority topics of research by the NIH Office of AIDS Research (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html). In particular, bench-to-bedside translational studies of alcohol use as a risk factor impacting HIV prevention, latency, treatment effectiveness, and HIV-related comorbidities are strongly encouraged.
- Letter of Intent Due Date(s): March 16, 2019
- AIDS Application Due Date(s): April 16, 2019
RFA-AA-19-003 Expiration Date April 17, 2019
This FOA supports linked applications. Multiple PDs/PIs are allowed on any single application. Because the FOA already supports a team approach between groups of experts across sites and collaborating applications, the designation of multiple PDs/PIs on a single application may be less likely to apply. PD(s)/PI(s) from each linked application should not be designated as multiple PDs/PIs on each application of a collaborative set.
The PD(s)/PI(s) of at least 1 of the collaborative application(s) must be a currently NIAAA funded PD(s)/PI(s) with established alcohol research programs. The PD(s)/PI(s) of at least 1 of the collaborative application(s) must be have with expertise in HIV/AIDS but may or may not be currently funded by NIAAA.
The application may not exceed $1.2 million direct costs per year.
The maximum project period is 5 years